Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On Thursday 4 May, the Nuffield Department of Surgical Sciences (NDS) hosted a special information day for patients with prostate cancer participating in the WINGMEN clinical trial.

Selena Kim, Valentine Macaulay and Martin Pirkl looking at the research poster for the patients
From L-R: Selena Kim, Valentine Macaulay and Martin Pirkl

The WINGMEN trial aims to understand how a hormone-like protein called insulin-like growth factor (IGF) helps prostate cancers grow and become aggressive. IGF is required for normal development, and also helps cancers grow and spread. Men with high blood IGF are at increased risk of developing prostate cancer, and tall men are more likely to get aggressive prostate cancer. The men with prostate cancer participating on the WINGMEN trial have been offered an operation to remove the prostate. Most men have to wait four to five weeks between a decision to have prostate removal surgery, and actually having the operation. In this four to five week window, the participants were treated with a new IGF-blocker drug called xentuzumab. 

Between March 2022 and March 2023, Dr Valentine Macaulay (Emeritus Associate Professor and Honorary Consultant in Medical Oncology) and Martin Pirkl (Research Coordinator) from NDS recruited 27 men with localised prostate cancer to the WINGMEN trial. The recruits and their families have been very interested in what the scientists will do with their samples and the information day was an opportunity to explain the research and thank all those involved.

Held in the Old Road Campus Research Building (ORCRB) on the Churchill Hospital site, the day featured a mixture of short talks given by:

  • Mr Alastair Lamb to explain robotic prostate surgery and his current research; 
  • Associate Professor Clare Verrill who explained what pathology is and how she is introducing digital pathology; 
  • Dr Valentine Macaulay to describe the research being carried out on the patients’ blood and tissues, and;
  • Dr Hayley Luxton, who is the Senior Research Impact and Intelligence Manager at Prostate Cancer UK - the charity funding the trial.

Read more about the information day on the Nuffield Department of Surgical Sciences website

Similar stories

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.